Fourth Quarter 2025 Earnings February 2, 2026 Safe Harbor This presentation contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, plans concerning business development opportunities, acquisitions or divestitures. Words such as "be ...

1 These forward-looking statements are based on our current expectations and beliefs and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such risks and uncertainties include, but are not limited to, risks associated with our development work, including any delays or changes to the timing, cost and success of our product development activities and clinical trials and plans for Anaphylm; risk of del ...

February 2, 2026 APTIV Fourth Quarter 2025 Earnings Call Forward-Looking Statements This presentation, as well as other statements made by Aptiv PLC (the "Company"), contain forward-looking statements that reflect, when made, the Company's current views with respect to current events, certain investments and acquisitions and financial performance. Such forward-looking statements are subject to many risks, uncertainties and factors relating to the Company's operations and business environment, which may caus ...

Certain of the statements made and information provided in this presentation forward-looking statements or information within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Often, these forward-looking statements and forward-looking information can be identified by the use of words such as "anticipates", "believes", "budget", "continue", "estimates", "expects", "forecasts", "guidance", "intends", "plans", "projected" or "scheduled" ...

Progressing the first Radio-DARPin Therapeutic MP0712 (212Pb x DLL3) for SCLC into the clinic ➢New patient imaging and dosimetry data ➢Update on Phase 1/2a study Patrick Amstutz, CEO Webcast call following TWC 2026 presentation February 2, 2026 Disclaimer This presentation contains forward looking statements. Any statements contained in this presentation that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of ...

Investor Relations 2026 In risk management, timing is everything. We act fast to provide the right support at the right moment - keeping claims on track and people on the path to recovery. We stand on experience Decades of delivering results have made us a proven partner for organizations nationwide. We bring consistency, care, and a deep understanding of what drives better outcomes. We Push Care Forward For us, innovation means more than technology. It's about combining powerful tools with the empathy and ...

FEBRUARY 2026 INVESTOR PRESENTATION CAUTIONARY STATEMENTS Statements in this presentation that are not historical in nature are considered "forward-looking statements" and are subject to change based on various risk factors and uncertainties that may cause actual results to differ significantly from expectations. Those factors are contained in AMETEK's Securities and Exchange Commission filings. AMETEK disclaims any intention or obligation to update or revise any forward-looking statements. In this presenta ...

Summary of Financial Results for the Third Quarter of FY2025 (Under Japanese GAAP) February 2, 2026 Mizuho and Art Based on the concepts of "Feeling Energized by Art," "Making Art More Accessible," and "Changing yourself through Art," Mizuho, in collaboration with Tokyo University of the Arts, contributes to social innovation, and the overcoming of social challenges like improving gender equality and people's well- being, aiming to co-create a sustainable and abundant society in terms of its art and culture ...

NASDAQ: FBIZ Earnings Release Supplement Fourth Quarter 2025 Forward-Looking Statements When used in this presentation, and in any other oral statements made with the approval of an authorized executive officer, the words or phrases "may," "could," "should," "hope," "might," "believe," "expect," "plan," "assume," "intend," "estimate," "anticipate," "project," "likely," or similar expressions are intended to identify "forward‐looking statements" within the meaning of such term in the Private Securities Litig ...

4 th Quarter 2025 Earnings Call January 30, 2026 | | Q4 2025 | Q3 2025 | | --- | --- | --- | | Net Income ($mm) | $69.9 | $73.8 | | Diluted EPS | $0.56 | $0.59 | | Net Interest Margin | 3.21% | 3.19% | | Efficiency Ratio | 55.1% | 55.3% | | ROA / ROATA2 | 1.16% / 1.21% | 1.22% / 1.27% | | ROE / ROATCE2 | 10.07% / 15.76% | 10.81% / 17.08% | | Tier 1 Leverage Ratio | 9.27% | 9.16% | | CET1 Capital Ratio | 13.17% | 13.24% | | Total Capital ratio | 14.42% | 14.49% | | Dividend3 | $0.26 / share | $0.26 / share | ...